Authors

• Eduardo Mysler (ORCID: https://orcid.org/0000-0002-8993-0313)
• K. Kwok
• Kunihiro Yamaoka (ORCID: https://orcid.org/0000-0001-8858-9435)
• Roy Fleischmann (ORCID: https://orcid.org/0000-0002-6630-1477)
• Shigeyuki Toyoizumi (ORCID: https://orcid.org/0000-0002-7011-5263)
• Noriko Iikuni (ORCID: https://orcid.org/0000-0002-5541-9314)
• Robert J. Moots (ORCID: https://orcid.org/0000-0001-7019-6211)
• N. Sugiyama
• Wen-Chan Tsai
• Josef S. Smolen
• Yoshiya Tanaka
• Tsutomu Takeuchi

Institutions

• Edge Hill University (GB)
• Pfizer (United States) (US)
• University of Occupational and Environmental Health Japan (JP)
• Keio University (JP)
• Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
• Metroplex Clinical Research Center (US)
• Southwestern Medical Center (US)
• Pfizer (Japan) (JP)
• Sanno Medical Center (JP)
• Kitasato University (JP)
• Medical University of Vienna (AT)
• Saitama Medical University (JP)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

Rheumatology and Therapy

Published

2026-01-22

DOI

https://doi.org/10.1007/s40744-025-00823-0

Primary Topic

Rheumatoid Arthritis Research and Therapies

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Pfizer
• AstraZeneca
• Astellas Pharma